The Oncosearch | Oncotarget

Cost-effectiveness of gefitinib, icotinib, and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China Research Paper

Shun Lu, Ming Ye, Lieming Ding, Fenlai Tan, Jie Fu, Bin Wu

Published Dec 27, 2016 · Vol. 8, No. 6 · pp. 9996-10006

A novel glutaminase inhibitor-968 inhibits the migration and proliferation of non-small cell lung cancer cells by targeting EGFR/ERK signaling pathway Research Paper

Tianyu Han, Meng Guo, Tingting Zhang, Mingxi Gan, Caifeng Xie, Jian-Bin Wang

Published Dec 26, 2016 · Vol. 8, No. 17 · pp. 28063-28073

Preclinical efficacy of Sym004, novel anti-EGFR antibody mixture, in esophageal squamous cell carcinoma cell lines Research Paper

Shota Fukuoka, Takashi Kojima, Yoshikatsu Koga, Mayumi Yamauchi, Masayuki Komatsu, Rie Komatsuzaki, Hiroki Sasaki, Masahiro Yasunaga, Yasuhiro Matsumura, Toshihiko Doi, Atsushi Ohtsu

Published Dec 26, 2016 · Vol. 8, No. 7 · pp. 11020-11029

Genomic regulation of invasion by STAT3 in triple negative breast cancer Research Paper

Joy M. McDaniel, Katherine E. Varley, Jason Gertz, Daniel S. Savic, Brian S. Roberts, Sarah K. Bailey, Lalita A. Shevde, Ryne C. Ramaker, Brittany N. Lasseigne, Marie K. Kirby, Kimberly M. Newberry, E. Christopher Partridge, Angela L. Jones, Braden Boone, Shawn E. Levy, Patsy G. Oliver, Katherine C. Sexton, William E. Grizzle, Andres Forero, Donald J. Buchsbaum, Sara J. Cooper, Richard M. Myers

Published Dec 24, 2016 · Vol. 8, No. 5 · pp. 8226-8238

Radiolabeled novel mAb 4G1 for immunoSPECT imaging of EGFRvIII expression in preclinical glioblastoma xenografts Research Paper

Xujie Liu, Chengyan Dong, Jiyun Shi, Teng Ma, Zhongxia Jin, Bing Jia, Zhaofei Liu, Li Shen, Fan Wang

Published Dec 22, 2016 · Vol. 8, No. 4 · pp. 6364-6375

Similar outcomes between adenoid cystic carcinoma of the breast and invasive ductal carcinoma: a population-based study from the SEER 18 database Research Paper

Qing-Xia Chen, Jun-Jing Li, Xiao-Xiao Wang, Pei-Yang Lin, Jie Zhang, Chuan-Gui Song, Zhi-Ming Shao

Published Dec 20, 2016 · Vol. 8, No. 4 · pp. 6206-6215

Mechanisms of resistance to anti-EGFR therapy in colorectal cancer Research Paper

Ben Zhao, Lu Wang, Hong Qiu, Mingsheng Zhang, Li Sun, Ping Peng, Qianqian Yu, Xianglin Yuan

Published Dec 18, 2016 · Vol. 8, No. 3 · pp. 3980-4000

The role of T790M mutation in EGFR-TKI re-challenge for patients with EGFR-mutant advanced lung adenocarcinoma Research Paper

Qiuyi Zhang, Ee Ke, Feiyu Niu, Wei Deng, Zhihong Chen, Chongrui Xu, Xuchao Zhang, Ning Zhao, Jian Su, Jinji Yang, Honghong Yan, Yilong Wu, Qing Zhou

Published Dec 17, 2016 · Vol. 8, No. 3 · pp. 4994-5002

Guide to detecting epidermal growth factor receptor (EGFR) mutations in ctDNA of patients with advanced non-small-cell lung cancer Review

Nicola Normanno, Marc G. Denis, Kenneth S. Thress, Marianne Ratcliffe, MartinÂ Reck

Published Dec 12, 2016 · Vol. 8, No. 7 · pp. 12501-12516

Induction chemotherapy followed by concurrent chemoradiation and nimotuzumab for locoregionally advanced nasopharyngeal carcinoma: preliminary results from a phase II clinical trial Research Paper

Jian-feng Huang, Fu-zheng Zhang, Qin-zhou Zou, Le-yuan Zhou, Bo Yang, Jian-jun Chu, Jia-hua Yu, Hao-wen Zhang, Xiao-peng Yuan, Guo-mei Tai, Fen-ju Liu, C-M Charlie Ma

Published Dec 10, 2016 · Vol. 8, No. 2 · pp. 2457-2465

Analysis of progression-free survival of first-line tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring leu858Arg or exon 19 deletions Research Paper

Feng-Che Kuan, Shih-Hong Li, Chih-Liang Wang, Meng-Hung Lin, Ying-Huang Tsai, Cheng-Ta Yang

Published Dec 7, 2016 · Vol. 8, No. 1 · pp. 1343-1353

Paradoxical induction of growth arrest and apoptosis by EGF via the up-regulation of PTEN by activating Redox factor-1/Egr-1 in human lung cancer cells Research Paper

Je-won Ryu, Sung Sik Choe, Seung-Hee Ryu, Eun-Young Park, Byoung Wook Lee, Tae Keun Kim, Chang Hoon Ha, Sang-wook Lee

Published Dec 7, 2016 · Vol. 8, No. 3 · pp. 4181-4195

An open label phase II study evaluating first-line EGFR tyrosine kinase inhibitor erlotinib in non-small cell lung cancer patients with tumors showing high EGFR gene copy number Clinical Research Papers

Ewa Szutowicz-ZieliÅ„ska, Krzysztof Konopa, Anna Kowalczyk, MaÅ‚gorzata Suszko-KaÅ¼arnowicz, Renata Duchnowska, Aleksandra SzczÄ™sna, Magdalena Ratajska, Aleksander Sowa, Janusz Limon, Wojciech Biernat, Tomasz Burzykowski, Jacek Jassem, RafaÅ‚ Dziadziuszko

Published Dec 4, 2016 · Vol. 8, No. 10 · pp. 17270-17278

Toward the use of precision medicine for the treatment of head and neck squamous cell carcinoma Research Paper

Wang Gong, Yandi Xiao, Zihao Wei, Yao Yuan, Min Qiu, Chongkui Sun, Xin Zeng, Xinhua Liang, Mingye Feng, Qianming Chen Chen

Published Dec 4, 2016 · Vol. 8, No. 2 · pp. 2141-2152

The association between clinical prognostic factors and epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) efficacy in advanced non-small-cell lung cancer patients: a retrospective assessment of 94 cases with EGFR mutations Research Paper

Jing-Hui Lin, Dong Lin, Ling Xu, Qiang Wang, Hui-Hua Hu, Hai-Peng Xu, Zhi-Yong He

Published Dec 3, 2016 · Vol. 8, No. 2 · pp. 3412-3421

EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect Research Paper

Qilin Xu, Qunzhou Zhang, Yasutaka Ishida, Souren Hajjar, Xudong Tang, Haoran Shi, Chi V. Dang, Anh D. Le

Published Dec 1, 2016 · Vol. 8, No. 6 · pp. 9557-9571

Phase I study of QLNC120, a novel EGFR and HER2 kinase inhibitor, in pre-treated patients with HER2-overexpressing advanced breast cancer Clinical Research Papers

Tongtong Zhang, Qing Li, Shanshan Chen, Yang Luo, Ying Fan, Binghe Xu

Published Nov 25, 2016 · Vol. 8, No. 22 · pp. 36750-36760

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Cost-effectiveness of gefitinib, icotinib, and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China Research Paper

A novel glutaminase inhibitor-968 inhibits the migration and proliferation of non-small cell lung cancer cells by targeting EGFR/ERK signaling pathway Research Paper

Preclinical efficacy of Sym004, novel anti-EGFR antibody mixture, in esophageal squamous cell carcinoma cell lines Research Paper

Genomic regulation of invasion by STAT3 in triple negative breast cancer Research Paper

Radiolabeled novel mAb 4G1 for immunoSPECT imaging of EGFRvIII expression in preclinical glioblastoma xenografts Research Paper

Similar outcomes between adenoid cystic carcinoma of the breast and invasive ductal carcinoma: a population-based study from the SEER 18 database Research Paper

Mechanisms of resistance to anti-EGFR therapy in colorectal cancer Research Paper

The role of T790M mutation in EGFR-TKI re-challenge for patients with EGFR-mutant advanced lung adenocarcinoma Research Paper

Guide to detecting epidermal growth factor receptor (EGFR) mutations in ctDNA of patients with advanced non-small-cell lung cancer Review

Induction chemotherapy followed by concurrent chemoradiation and nimotuzumab for locoregionally advanced nasopharyngeal carcinoma: preliminary results from a phase II clinical trial Research Paper

Analysis of progression-free survival of first-line tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring leu858Arg or exon 19 deletions Research Paper

Paradoxical induction of growth arrest and apoptosis by EGF via the up-regulation of PTEN by activating Redox factor-1/Egr-1 in human lung cancer cells Research Paper

An open label phase II study evaluating first-line EGFR tyrosine kinase inhibitor erlotinib in non-small cell lung cancer patients with tumors showing high EGFR gene copy number Clinical Research Papers

Toward the use of precision medicine for the treatment of head and neck squamous cell carcinoma Research Paper

The association between clinical prognostic factors and epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) efficacy in advanced non-small-cell lung cancer patients: a retrospective assessment of 94 cases with EGFR mutations Research Paper

EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect Research Paper

Long-term tolerance and cardiac function in breast cancer patients receiving trastuzumab therapy Research Paper

Cortactin promotes colorectal cancer cell proliferation by activating the EGFR-MAPK pathway Research Paper

CDH1 regulates E2F1 degradation in response to differentiation signals in keratinocytes Research Paper

Phase I study of QLNC120, a novel EGFR and HER2 kinase inhibitor, in pre-treated patients with HER2-overexpressing advanced breast cancer Clinical Research Papers

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Cost-effectiveness of gefitinib, icotinib, and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China Research Paper

A novel glutaminase inhibitor-968 inhibits the migration and proliferation of non-small cell lung cancer cells by targeting EGFR/ERK signaling pathway Research Paper

Preclinical efficacy of Sym004, novel anti-EGFR antibody mixture, in esophageal squamous cell carcinoma cell lines Research Paper

Genomic regulation of invasion by STAT3 in triple negative breast cancer Research Paper

Radiolabeled novel mAb 4G1 for immunoSPECT imaging of EGFRvIII expression in preclinical glioblastoma xenografts Research Paper

Similar outcomes between adenoid cystic carcinoma of the breast and invasive ductal carcinoma: a population-based study from the SEER 18 database Research Paper

Mechanisms of resistance to anti-EGFR therapy in colorectal cancer Research Paper

The role of T790M mutation in EGFR-TKI re-challenge for patients with EGFR-mutant advanced lung adenocarcinoma Research Paper

Guide to detecting epidermal growth factor receptor (EGFR) mutations in ctDNA of patients with advanced non-small-cell lung cancer Review

Induction chemotherapy followed by concurrent chemoradiation and nimotuzumab for locoregionally advanced nasopharyngeal carcinoma: preliminary results from a phase II clinical trial Research Paper

Analysis of progression-free survival of first-line tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring leu858Arg or exon 19 deletions Research Paper

Paradoxical induction of growth arrest and apoptosis by EGF via the up-regulation of PTEN by activating Redox factor-1/Egr-1 in human lung cancer cells Research Paper

An open label phase II study evaluating first-line EGFR tyrosine kinase inhibitor erlotinib in non-small cell lung cancer patients with tumors showing high EGFR gene copy number Clinical Research Papers

Toward the use of precision medicine for the treatment of head and neck squamous cell carcinoma Research Paper

The association between clinical prognostic factors and epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) efficacy in advanced non-small-cell lung cancer patients: a retrospective assessment of 94 cases with EGFR mutations Research Paper

EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect Research Paper

Long-term tolerance and cardiac function in breast cancer patients receiving trastuzumab therapy Research Paper

Cortactin promotes colorectal cancer cell proliferation by activating the EGFR-MAPK pathway Research Paper

CDH1 regulates E2F1 degradation in response to differentiation signals in keratinocytes Research Paper

Phase I study of QLNC120, a novel EGFR and HER2 kinase inhibitor, in pre-treated patients with HER2-overexpressing advanced breast cancer Clinical Research Papers